Blood Collection Market

By Collection Site;

Venous [Needles & Syringes (Double-Ended Needles, Winged Blood Collection Sets, Standard Hypodermic Needles and Others), Blood Collection Tubes (Serum-Separating, EDTA, Heparin and Plasma-Separating), Blood Bags and Others] and Capillary [Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices and Others]

By Application;

Diagnostics and Treatment

By Collection Method;

Manual Blood Collection and Automated Blood Collection

By End Use;

Hospitals, Diagnostics Centers, Blood Banks, Emergency Departments and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn730825526 Published Date: September, 2025 Updated Date: November, 2025

Blood Collection Market Overview

Blood Collection Market (USD Million)

Blood Collection Market was valued at USD 7,687.09 million in the year 2024. The size of this market is expected to increase to USD 11,635.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.


Blood Collection Market

*Market size in USD million

CAGR 6.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.1 %
Market Size (2024)USD 7,687.09 Million
Market Size (2031)USD 11,635.09 Million
Market ConcentrationMedium
Report Pages379
7,687.09
2024
11,635.09
2031

Major Players

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics
  • Fresenius Kabi AG

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Blood Collection Market

Fragmented - Highly competitive market without dominant players


The Blood Collection Market is expanding rapidly due to its vital role in diagnostics and treatment. Nearly 60% of medical interventions depend on blood testing or transfusion, reflecting its importance in healthcare. More than 55% of patients undergo routine blood tests, making this industry a cornerstone of modern medical practices.

Innovations Driving Safer Practices
The adoption of advanced blood collection devices has improved efficiency and safety. Automated systems now account for almost 40% of all collections, reducing errors and contamination. Over 45% of laboratories are shifting to closed-system devices, ensuring sterility and enhancing patient as well as operator safety.

Expanding Need for Transfusions and Testing
The rising demand for blood transfusions and diagnostic screening strengthens market growth. More than 50% of emergency medical procedures require immediate blood supplies, while close to 35% of disease diagnoses rely on blood analysis. This dependency highlights the significance of robust collection systems in healthcare delivery.

Digital Integration and Automation
The market is embracing digital and automated solutions to improve efficiency. Around 50% of healthcare providers use automated monitoring for traceability and error reduction. Meanwhile, over 45% of blood banks rely on digital tracking systems, showcasing the sector’s steady move toward smart and efficient practices.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Site
    2. Market Snapshot, By Application
    3. Market Snapshot, By Method
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Blood Collection Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Healthcare Demand
        2. Advancements in Technology
        3. Growing Geriatric Population
        4. Rising Prevalence Rates
        5. Blood Donation Awareness
      2. Restraints
        1. Regulatory Compliance Challenges
        2. Limited Blood Donors
        3. Cost Constraints
        4. Blood Collection Safety
        5. Cultural and Social Factors
      3. Opportunities
        1. Emerging Markets Expansion
        2. Technological Innovations Integration
        3. Collaboration with Healthcare Institutions
        4. Increased Blood Banking
        5. Mobile Blood Drives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Blood Collection Market, By Site, 2021 - 2031 (USD Million)
      1. Venous
      2. Capillary
    2. Blood Collection Market, By Application, 2021 - 2031 (USD Million)
      1. Diagnostics
      2. Treatment
    3. Blood Collection Market, By Method, 2021 - 2031 (USD Million)
      1. Manual Blood Collection
      2. Automated Blood Collection
    4. Blood Collection Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Diagnostics Centers
      3. Blood Banks
      4. Emergency Departments
      5. Others
    5. Blood Collection Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Laboratories
      2. Becton, Dickinson and Company (BD)
      3. Cardinal Health
      4. Terumo Corporation
      5. Greiner Bio-One International GmbH
      6. Haemonetics Corporation
      7. Medtronic plc
      8. QIAGEN N.V.
      9. Nipro Corporation
      10. Fresenius SE & Co. KGaA
      11. Sarstedt AG & Co. KG
      12. FL Medical S.r.l.
      13. McKesson Corporation
      14. Streck, Inc.
      15. Siemens Healthineers
  7. Analyst Views
  8. Future Outlook of the Market